| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |